Arctic daily sea ice extent continued to hover near record daily lows in January, with the ice edge well northward of its long-term average position in most areas. In contrast to the cold conditions ...

Leaders involved in the 2023-2024 deployments of the Wasp and Boxer Amphibious Ready Groups, or ARGs, described the ...

The U.S. Navy aircraft carrier USS Carl Vinson (CVN-70) arrived at the port of Laem Chabang, Thailand, a few days ago for a scheduled visit after three weeks of operations in the South China Sea. In ...

On June 19, 1864, the Union sloop-of-war USS Kearsarge laid in wait outside ... from the main theater of the Civil War, it was a famous sea duel then. At the time, the action became known as ...

NEW YORK (AP) — A New York judge set a March 2026 trial date on Monday and moved an initial conference from mid-February to next week as the public feud between Blake Lively and her “It Ends ...

It ends in court — next year. Blake Lively and Justin Baldoni are headed to trial on March 9, 2026 to settle their “It Ends With Us” legal dispute. The court date for the case was scheduled ...

A witness in the case of an alleged murder at sea was accused of lying in court this morning by ... but rather in a warmer compartment within the hold. The trial is scheduled to resume this afternoon.

ABOARD A FRENCH NAVY FLIGHT OVER THE BALTIC SEA — With its powerful camera, the French Navy surveillance plane scouring the Baltic Sea zoomed in on a cargo ship plowing the waters below—closer ...

The pre-pivotal clinical trial, which included 30 diabetic participants—primarily individuals with Type 1 diabetes—represents a significant milestone in Trinity's mission to deliver affordable ...

Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing interest. All that’s needed: brave volunteers. Credit...Jon Han Supported ...

A Phase III trial demonstrated that adding nivolumab, an immunotherapy drug, to pre-surgery chemotherapy significantly improves cure rates for ER+/HER2− breast cancer, the most common subtype.